New Page: S&P500 Companies Overview
see insider trading activities and stock performance analytics over the past year - Click here
New Page: S&P500 Companies Overview
see insider trading activities and stock performance analytics over the past year - Click here
Home > VERTEX PHARMACEUTICALS INC / MA
VERTEX PHARMACEUTICALS INC / MA
Industry: Life Sciences ・ $VRTX on Nasdaq ・ Market Cap: Large
CEO Sales
Top Executive Recent Sales
1Y INSIDER TRADING ACTIVITY
Insider Trade Volume in USD
1Y INSIDER ACTIVITY
| TRADES PURCHASE/SALE Sector Average | 0 / 38 2.19 / 7.65 |
| INSIDER BUYERS/SELLERS Sector Average | 0 / 12 1.2 / 2.5 |
| SHARES PURCHASED/SOLD Transaction Average | 0 / 122,592 0 / 3,226 |
| VALUE PURCHASED/SOLD Transaction Average | $0 / $57,292,672 $0 / $1,507,702 |
| PURCHASE RANGE | N/A |
| SALE RANGE | $111,034.64 - $7,677,010 |
INSIDER PERFORMANCE OVERVIEW
PURCHASE PERFORMANCE
0 / 8
CEO Purchases
Top Executive Purchases
New Purchase Insider
High Purchase Reporters Count
High Purchase Activity
Regular Purchase Insiders
Abnormal High-Volume Purchases
High Purchases Frequency
SALE PERFORMANCE
2 / 4
CEO Sales
Top Executive Sales
Regular Sale Insiders
High Sales Frequency
1Y PURCHASE DISTRIBUTION
purchase distribution by individual insiders
No Insider Trades made
0%
DIRECTORS
0%
OFFICERS
0%
10% OWNERS
0%
OTHERS
SHARES GINI INDEX Sector Average | N/A 0.2 |
VALUE GINI INDEX Sector Average | N/A 0.206 |
1Y SALE DISTRIBUTION
sale distribution by individual insiders
47.08%
DIRECTORS
52.92%
OFFICERS
0%
10% OWNERS
0%
OTHERS
SHARES GINI INDEX Sector Average | 0.364 0.295 |
VALUE GINI INDEX Sector Average | 0.351 0.288 |
VERTEX PHARMACEUTICALS INC / MA 1Y Trade Transactions
Submission Date Period of Report | Insider | Position | Total Value | Shares | Share Price | Ownership % Change | Shares Owned | Post Day Stock Change | Post Week Stock Change | |
|---|---|---|---|---|---|---|---|---|---|---|
2025-02-19 2025-02-14 | Tatsis Ourania | Officer | -$111,035 | 244 | $455.06 | -0.36% | 67,695 | N/A | N/A | |
2025-02-12 2025-02-10 | Tatsis Ourania | Officer | -$142,547 | 310 | $459.83 | -0.48% | 64,021 | N/A | N/A | |
2025-02-12 2025-02-10 | Biller Jonathan | Officer | -$1,578,734 | 3,433 | $459.87 | -17.37% | 16,330 | N/A | N/A | |
2025-02-12 2025-02-10 | Atkinson Edward Morrow III | Officer | -$803,323 | 1,747 | $459.83 | -7% | 23,225 | N/A | N/A | |
2025-02-12 2025-02-10 | Ambrose Kristen | Officer | -$632,726 | 1,376 | $459.83 | -12.15% | 9,953 | N/A | N/A | |
2024-11-13 2024-11-11 | WAGNER CHARLES F JR | Officer | -$1,554,810 | 3,000 | $518.27 | -6.36% | 44,137 | N/A | N/A | |
2024-10-03 2024-10-01 | Biller Jonathan | Officer | -$461,198 | 999 | $461.66 | -5.66% | 16,651 | N/A | N/A | |
2024-09-04 2024-08-30 | LEIDEN JEFFREY M | Director | -$1,888,216 | 3,784 | $499 | -26.61% | 10,434 | -2.09% | -0.80% | |
2024-09-04 2024-08-30 | Bhatia Sangeeta N. | Director | -$323,000 | 646 | $500 | -12.71% | 4,435 | -2.09% | -0.80% | |
2024-08-12 2024-08-08 | Bhatia Sangeeta N. | Director | -$602,447 | 1,292 | $466.29 | -22.56% | 4,435 | +1.23% | +5.07% |